{"content":"<li class=\"n-box-item date-title\" data-end=\"1512795599\" data-start=\"1512709200\" data-txt=\"Monday, December 23, 2019\">Friday, December  8, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3317354\" data-ts=\"1512772517\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317354-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/UTSI' title='UTStarcom, Inc.'>UTSI</a> <font color='green'>+7.6%</font>. <a href='https://seekingalpha.com/symbol/FATE' title='Fate Therapeutics, Inc.'>FATE</a> <font color='green'>+6.5%</font>. <a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a> <font color='green'>+3.8%</font>. <a href='https://seekingalpha.com/symbol/IMDZ' title='Immune Design'>IMDZ</a> <font color='green'>+3.8%</font>. <a href='https://seekingalpha.com/symbol/VSTM' title='Verastem, Inc.'>VSTM</a> <font color='green'>+3.9%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/CYTK' title='Cytokinetics, Incorporated'>CYTK</a> <font color='red'>-5.0%</font>. <a href='https://seekingalpha.com/symbol/DERM' title='Dermira'>DERM</a> <font color='red'>-4.6%</font>. <a href='https://seekingalpha.com/symbol/SGRY' title='Surgery Partners, Inc.'>SGRY</a> <font color='red'>-2.6%</font>. <a href='https://seekingalpha.com/symbol/VSAR-OLD' title='Versartis, Inc.'>VSAR-OLD</a> <font color='red'>-2.2%</font>. <a href='https://seekingalpha.com/symbol/QURE' title='uniQure N.V.'>QURE</a> <font color='red'>-2.2%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3317354\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$UTSI $FATE $OSTK - After Hours Gainers / Losers https://seekingalpha.com/news/3317354-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3317354-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317339\" data-ts=\"1512769924\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317339-weekly-etf-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekly ETF Gainers / Losers</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/URA' title='Global X Uranium ETF'>URA</a> <font color='green'>+9.7%</font>. <a href='https://seekingalpha.com/symbol/EPI' title='WisdomTree India Earnings ETF'>EPI</a> <font color='green'>+2.2%</font>. <a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a> <font color='green'>+1.5%</font>. <a href='https://seekingalpha.com/symbol/XLI' title='Industrial Select Sector SPDR ETF'>XLI</a> <font color='green'>+1.5%</font>. <a href='https://seekingalpha.com/symbol/UUP' title='PowerShares DB USD Bull ETF'>UUP</a> <font color='green'>+1.1%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/GAZ' title='iPath DJ-UBS Natural Gas Total Return Sub-Index ETN'>GAZ</a> <font color='red'>-10.7%</font>. <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a> <font color='red'>-9.3%</font>. <a href='https://seekingalpha.com/symbol/VXX' title='iPath S&P 500 VIX Short-Term Futures ETN'>VXX</a> <font color='red'>-7.6%</font>. <a href='https://seekingalpha.com/symbol/REMX' title='VanEck Vectors Rare Earth/Strategic Metals ETF'>REMX</a> <font color='red'>-5.3%</font>. <a href='https://seekingalpha.com/symbol/GDXJ' title='VanEck Vectors Junior Gold Miners ETF'>GDXJ</a> <font color='red'>-4.4%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3317339\" data-linked=\"Weekly ETF Gainers / Losers\" data-tweet=\"$URA $EPI $XLF - Weekly ETF Gainers / Losers https://seekingalpha.com/news/3317339-weekly-etf-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3317339-weekly-etf-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317330\" data-ts=\"1512769148\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKTX\" target=\"_blank\">AKTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317330-akaris-coversin-successful-in-mid-stage-pnh-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Akari&#39;s Coversin successful in mid-stage PNH study</a></h4><ul><li>A Phase 2 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02591862?term=coversin&amp;rank=1\" target=\"_blank\">COBALT</a>, assessing Akari Therapeutics' (NASDAQ:<a href='https://seekingalpha.com/symbol/AKTX' title='Akari Therapeutics Plc'>AKTX</a>) lead candidate Coversin in patients with paroxysmal nocturnal hemoglobinuria &#40;PNH&#41; <a href=\"https://seekingalpha.com/pr/17022565-akari-therapeutics-announces-phase-ii-cobalt-trial-coversin-patients-pnh-met-primary-endpoint\" target=\"_blank\">met the primary endpoint</a> of a statistically significant reduction in LDH (lactate dehydrogenase) to within 1.8x the upper limit of normal &#40;ULN&#41; by day 28 (a reduction to within 2x of ULN within 28 days is considered successful).</li><li>The last three patients enrolled, treated with the higher dose of 45 mg, experienced a drop in LDH to 1.5x the ULN at day 14 and below 1.5x the ULN at day 28 and day 60. Subjects receiving the 30 mg dose showed a median LDH value of 2.2x the ULN at day 28 and 1.7x the ULN at day 60.</li><li>Half (n=3/6) of the transfusion-dependent patients at study entry did not a require transfusion while on Coversin therapy during COBALT or the long-term safety study.</li><li>Two Phase 3 studies evaluating the 45 mg/day dose should commence next quarter. CAPSTONE will assess Coversin in treatment-naive PNH patients and ASSET will include patients that will switch from Alexion Pharmaceuticals' (NASDAQ:<a href='https://seekingalpha.com/symbol/ALXN' title='Alexion Pharmaceuticals, Inc.'>ALXN</a>) Soliris (eculizumab).</li><li>Coversin is a second-generation complement inhibitor.</li><li>Management will host an investor and analyst event on Sunday, December 10 at 8:00 pm ET.</li><li>Shares are up&nbsp;<font color='green'>1%</font>&nbsp;after hours on light volume.</li><li>PNH-related tickers: <a href='https://seekingalpha.com/symbol/RARX' title='Ra Pharmaceuticals'>RARX</a> <a href='https://seekingalpha.com/symbol/ACHN' title='Achillion Pharmaceuticals, Inc.'>ACHN</a> <a href='https://seekingalpha.com/symbol/APLS' title='Apellis Pharmaceuticals, Inc.'>APLS</a> <a href='https://seekingalpha.com/symbol/RHHBY' title='Roche Holding Ltd ADR'>OTCQX:RHHBY</a> <a href='https://seekingalpha.com/symbol/FBIO' title='Fortress Biotech, Inc.'>FBIO</a> <a href='https://seekingalpha.com/symbol/EPRS' title='EPIRUS Biopharmaceuticals, Inc'>EPRS</a> <a href='https://seekingalpha.com/symbol/ALNY' title='Alnylam Pharmaceuticals, Inc.'>ALNY</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3317330\" data-linked=\"Akari&#39;s Coversin successful in mid-stage PNH study\" data-tweet=\"$AKTX $AKTX $ALXN - Akari&#39;s Coversin successful in mid-stage PNH study https://seekingalpha.com/news/3317330-akaris-coversin-successful-in-mid-stage-pnh-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3317330-akaris-coversin-successful-in-mid-stage-pnh-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317307\" data-ts=\"1512762789\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDSO\" target=\"_blank\">MDSO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317307-deutsche-bank-initiates-medidata\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche Bank initiates Medidata</a></h4><ul><li>        Deutsche Bank <a href=\"http://www.briefing.com/DisplayArticle/ArticlePopup.aspx?ArticleId=IN20171208133535MDSO\" target=\"_blank\">initiates</a> Medidata Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/MDSO' title='Medidata Solutions, Inc.'>MDSO</a>) with a Buy rating and $78 price target.</li><li>               The firm calls Medidata well positioned to benefit from positive long-term secular trends as the only company with an end-to-end clinical cloud platform.&nbsp;</li><li>                  Deutsche Bank sees the current valuation as reasonable compared to software peers.    </li><li>               Medidata shares are&nbsp;<font color='green'>up 1.3%</font>. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3317307\" data-linked=\"Deutsche Bank initiates Medidata\" data-tweet=\"$MDSO - Deutsche Bank initiates Medidata https://seekingalpha.com/news/3317307-deutsche-bank-initiates-medidata?source=tweet\" data-url=\"https://seekingalpha.com/news/3317307-deutsche-bank-initiates-medidata\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317306\" data-ts=\"1512762695\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317306-technology-top-gainers-losers-of-2-50-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2:50 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SIGM' title='Sigma Designs, Inc.'>SIGM</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/MARK' title='Remark Holdings, Inc.'>MARK</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/ITI' title='Iteris, Inc'>ITI</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/TCCO' title='Technical Communications Corp.'>TCCO</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/FSCT' title='ForeScout Technologies, Inc.'>FSCT</a> <font color='green'>+15%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/VECO' title='Veeco Instruments Inc.'>VECO</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/ATOM' title='Atomera Inc.'>ATOM</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/SSTI' title='ShotSpotter'>SSTI</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/SOFO' title='Sonic Foundry, Inc.'>OTC:SOFO</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3317306\" data-linked=\"Technology - Top Gainers / Losers as of 2:50 pm\" data-tweet=\"$SIGM $MARK $ITI - Technology - Top Gainers / Losers as of 2:50 pm https://seekingalpha.com/news/3317306-technology-top-gainers-losers-of-2-50-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3317306-technology-top-gainers-losers-of-2-50-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:51 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317305\" data-ts=\"1512762124\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEL\" target=\"_blank\">TEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317305-cross-research-upgrades-te-connectivity\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cross Research upgrades TE Connectivity</a></h4><ul><li>        Cross Research upgrades TE Connectivity (NYSE:<a href='https://seekingalpha.com/symbol/TEL' title='TE Connectivity Ltd.'>TEL</a>) from Hold to Buy.</li><li>               Latest analyst recommendations (via <a href=\"https://markets.ft.com/data/equities/tearsheet/forecasts?s=TEL:NYQ\" target=\"_blank\">FT</a>): 5 Buy, 4 Outperform, 3 Hold, and 1 Underperform.&nbsp;</li><li>               Median price target: $100.50.&nbsp;</li><li>               TE Connectivity shares are&nbsp;<font color='green'>up 0.75%</font>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3317185-te-connectivity-announces-1_5b-increase-share-repurchase-program\" target=\"_blank\">TE Connectivity announces $1.5B increase to its share repurchase program</a> (Dec. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3317305\" data-linked=\"Cross Research upgrades TE Connectivity\" data-tweet=\"$TEL - Cross Research upgrades TE Connectivity https://seekingalpha.com/news/3317305-cross-research-upgrades-te-connectivity?source=tweet\" data-url=\"https://seekingalpha.com/news/3317305-cross-research-upgrades-te-connectivity\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317304\" data-ts=\"1512761591\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAIC\" target=\"_blank\">SAIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317304-vertical-research-upgrades-science-applications\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vertical Research upgrades Science Applications</a></h4><ul><li>        Vertical Research <a href=\"https://www.google.com/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=web&amp;cd=2&amp;cad=rja&amp;uact=8&amp;ved=0ahUKEwjz-oWak_vXAhWM4IMKHcgmCf8QFggsMAE&amp;url=https%3A%2F%2Fwww.streetinsider.com%2FAnalyst%2BComments%2FVertical%2BResearch%2BPartners%2BUpgrades%2BScience%2BApplications%2B%28SAIC%29%2Bto%2BBuy%2F13582870.html&amp;usg=AOvVaw1GtjhET-Wcy8ma7jnf40sm\" target=\"_blank\">upgrades</a> Science Applications (NYSE:<a href='https://seekingalpha.com/symbol/SAIC' title='Science Applications International Corporation'>SAIC</a>) from Hold to Buy and raises the price target from $75 to $83.</li><li>               Analyst Krishna Sinha cites the Q3 revenue and margin beats with solid bookings and bid pipeline strength.&nbsp;&nbsp;</li><li>                  Science Applications shares are&nbsp;<font color='green'>up 6.9%</font>.    &nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3317304\" data-linked=\"Vertical Research upgrades Science Applications\" data-tweet=\"$SAIC - Vertical Research upgrades Science Applications https://seekingalpha.com/news/3317304-vertical-research-upgrades-science-applications?source=tweet\" data-url=\"https://seekingalpha.com/news/3317304-vertical-research-upgrades-science-applications\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317301\" data-ts=\"1512761084\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GIGM\" target=\"_blank\">GIGM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317301-gigamedia-ceo-purchases-additional-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GigaMedia CEO purchases additional shares</a></h4><ul><li>        GigaMedia (NASDAQ:<a href='https://seekingalpha.com/symbol/GIGM' title='GigaMedia Limited'>GIGM</a>) <a href=\"https://seekingalpha.com/pr/17022159-purchase-gigamedia-shares-ceo-cheng-ming-huang\" target=\"_blank\">announces</a> CEO Cheng-Ming Huang purchased 55,070 shares.</li><li>               Average share price was $2.9375.&nbsp;</li><li>               The CEO now holds 292,678 shares. &nbsp;&nbsp;</li><li>               GigaMedia shares are&nbsp;<font color='green'>up 2.8%</font>.&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3317301\" data-linked=\"GigaMedia CEO purchases additional shares\" data-tweet=\"$GIGM - GigaMedia CEO purchases additional shares https://seekingalpha.com/news/3317301-gigamedia-ceo-purchases-additional-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3317301-gigamedia-ceo-purchases-additional-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317299\" data-ts=\"1512760258\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSFT\" target=\"_blank\">MSFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317299-evercore-raises-microsoft-price-target-sees-1t-valuation-fy21\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Evercore raises Microsoft price target, sees $1T valuation by FY21</a></h4><ul><li>        Evercore ISI analysts think Microsoft (NASDAQ:<a href='https://seekingalpha.com/symbol/MSFT' title='Microsoft Corporation'>MSFT</a>) can hit a <a href=\"https://www.cnbc.com/2017/12/08/microsoft-could-reach-1-trillion-market-cap-by-2020-evercore.html\" target=\"_blank\">$1T market cap</a> by 2020.</li><li>                  The analysts cite Microsoft 365 products as a growth driver and expect the business to generate $26.86B in sales in FY21, which starts in the second half of 2020.    </li><li>                  Over $5B of that revenue will come from Office 365&rsquo;s consumer business.    </li><li>               The analysts also expect Microsoft&rsquo;s Azure cloud business to continue growing to FY21 sales of $22.19B.&nbsp;</li><li>               Price target raises from $93 to $106.&nbsp;</li><li>Microsoft shares are&nbsp;<font color='green'>up 2%.</font>&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3317030-eu-filing-brief-supreme-court-case-involving-microsoft-data\" target=\"_blank\">EU filing brief in Supreme Court case involving Microsoft data</a> (Dec. 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3317299\" data-linked=\"Evercore raises Microsoft price target, sees $1T valuation by FY21\" data-tweet=\"$MSFT - Evercore raises Microsoft price target, sees $1T valuation by FY21 https://seekingalpha.com/news/3317299-evercore-raises-microsoft-price-target-sees-1t-valuation-fy21?source=tweet\" data-url=\"https://seekingalpha.com/news/3317299-evercore-raises-microsoft-price-target-sees-1t-valuation-fy21\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317296\" data-ts=\"1512759671\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317296-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MCF' title='Contango Oil & Gas Company'>MCF</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/UAN' title='CVR Partners, LP'>UAN</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/CDXC' title='ChromaDex Inc.'>CDXC</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/NOG' title='Northern Oil & Gas, Inc'>NOG</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/SND' title='Smart Sand'>SND</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TELL' title='Tellurian Inc.'>TELL</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/WMLP-OLD' title='Westmoreland Resource Partners, LP'>WMLP-OLD</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/ERN' title='Erin Energy Corp.'>ERN</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3317296\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$MCF $UAN $CDXC - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3317296-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3317296-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317278\" data-ts=\"1512755404\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317278-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/PXS' title='Pyxis Tankers Inc.'>PXS</a> <font color='green'>+42%</font>. <a href='https://seekingalpha.com/symbol/SIGM' title='Sigma Designs, Inc.'>SIGM</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/CKPT' title='CHECKPOINT THERAPEUTICS'>CKPT</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/TCCO' title='Technical Communications Corp.'>TCCO</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/GLBS' title='Globus Maritime Ltd.'>GLBS</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/GALT' title='Galectin Therapeutics, Inc.'>GALT</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/ITI' title='Iteris, Inc'>ITI</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/MCF' title='Contango Oil & Gas Company'>MCF</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/MARK' title='Remark Holdings, Inc.'>MARK</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/NEPT' title='Neptune Wellness Solutions Inc.'>NEPT</a> <font color='green'>+16%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/DPW' title='DPW Holdings, Inc.'>DPW</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/AQMS' title='Aqua Metals'>AQMS</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/CGIX' title='Cancer Genetics, Inc.'>CGIX</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/VECO' title='Veeco Instruments Inc.'>VECO</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/TELL' title='Tellurian Inc.'>TELL</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/VTGN' title='VistaGen Therapeutics, Inc.'>VTGN</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/JOUT' title='Johnson Outdoors Inc.'>JOUT</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/AOBC' title='American Outdoor Brands Corporation'>AOBC</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/LJPC' title='La Jolla Pharmaceutical Co.'>LJPC</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/CVO' title='Cenveo, Inc.'>CVO</a> <font color='red'>-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3317278\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$PXS $SIGM $CKPT - Midday Gainers / Losers https://seekingalpha.com/news/3317278-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3317278-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317276\" data-ts=\"1512755135\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317276-digitimes-apple-suppliers-shipments-down-on-month-expect-weak-dec\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Digitimes: Apple suppliers shipments down on month, expect weak Dec.</a></h4><ul><li>        Digitimes <a href=\"https://www.digitimes.com/news/a20171208PD210.html\" target=\"_blank\">sources</a> report that Largan wasn&rsquo;t the only Apple (<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a> <font color='green'>+0.4%</font>) supplier that had weak shipments in November with a further drop expected this month.</li><li>               Catcher technology, a chassis maker, had revenue drop 10.4% on the month in November.&nbsp;</li><li>               General Interface Solutions, which provides touch panels, had a 15.53% decline after expecting sales to grow into next year.&nbsp;</li><li>               The sources say Apple lowered its iPhone X component orders 30% below forecast in November and expect the same sequential percentage drop in Q1 due to seasonality and fewer working days in the quarter. But Q1 shipments could grow on the year.&nbsp;</li><li>               Apple suppliers that can move with news: Skyworks (<a href='https://seekingalpha.com/symbol/SWKS' title='Skyworks Solutions, Inc.'>SWKS</a> <font color='red'>-0.1%</font>), Cirrus Logic (<a href='https://seekingalpha.com/symbol/CRUS' title='Cirrus Logic, Inc.'>CRUS</a> <font color='green'>+0.7%</font>), Qorvo (<a href='https://seekingalpha.com/symbol/QRVO' title='Qorvo, Inc'>QRVO</a> <font color='red'>-0.4%</font>), and Broadcom (<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Limited'>AVGO</a> <font color='red'>-0.3%</font>).&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3316960-apple-suppliers-recover-broadcom-sales-comments\" target=\"_blank\">Apple suppliers recover after Broadcom sales comments</a> (Dec. 7)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3316681-apple-suppliers-drop-largan-warns-lower-dec-revenue\" target=\"_blank\">Apple suppliers drop after Largan warns of lower Dec. revenue</a> (Dec. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3317276\" data-linked=\"Digitimes: Apple suppliers shipments down on month, expect weak Dec.\" data-tweet=\"$AAPL $AAPL $SWKS - Digitimes: Apple suppliers shipments down on month, expect weak Dec. https://seekingalpha.com/news/3317276-digitimes-apple-suppliers-shipments-down-on-month-expect-weak-dec?source=tweet\" data-url=\"https://seekingalpha.com/news/3317276-digitimes-apple-suppliers-shipments-down-on-month-expect-weak-dec\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317274\" data-ts=\"1512754768\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CELG\" target=\"_blank\">CELG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317274-celgene-up-3-ahead-of-ash-presentations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celgene up 3% ahead of ASH presentations</a></h4><ul><li>Celgene (<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color='green'>+2.7%</font>) is steadily climbing back from its late October selloff after its mongersen flop in Crohn's and Q3 revenue miss.</li><li>There is a long list of abstracts related the company's and collaboration partners Juno Therapeutics (<a href='https://seekingalpha.com/symbol/JUNO' title='Juno Therapeutics'>JUNO</a> <font color='green'>+1.8%</font>) and bluebird bio's (<a href='https://seekingalpha.com/symbol/BLUE' title='bluebird bio, Inc.'>BLUE</a> <font color='green'>+3.2%</font>) pipeline candidates that will be presented during the Annual Meeting of the American Society of Hematology in Atlanta, December 9 - 12.</li><li>Jefferies' Michael Yee is bullish on the company (BUY/$125) citing a turnaround play thesis led by bullish prospects for CAR-T therapies.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3317274\" data-linked=\"Celgene up 3% ahead of ASH presentations\" data-tweet=\"$CELG $CELG $JUNO - Celgene up 3% ahead of ASH presentations https://seekingalpha.com/news/3317274-celgene-up-3-ahead-of-ash-presentations?source=tweet\" data-url=\"https://seekingalpha.com/news/3317274-celgene-up-3-ahead-of-ash-presentations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317269\" data-ts=\"1512753839\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMGN\" target=\"_blank\">AMGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317269-coherus-to-prevail-in-amgen-patent-infringement-suit-shares-up-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coherus to prevail in Amgen patent infringement suit; shares up 4%</a></h4><ul><li>A U.S. Magistrate Judge has <a href=\"https://www.sec.gov/Archives/edgar/data/1512762/000119312517364648/d509627d8k.htm\" target=\"_blank\">recommended </a>that the U.S. District Court in Delaware dismiss plaintiff Amgen's (<a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a> <font color='green'>+1%</font>) complaint against Coherus Biosciences (<a href='https://seekingalpha.com/symbol/CHRS' title='Coherus BioSciences'>CHRS</a> <font color='green'>+3.6%</font>) for alleged infringement on <a href=\"https://www.google.com/patents/US8273707\" target=\"_blank\">U.S. Patent No. 8,273,707</a>.</li><li>Amgen <a href=\"https://www.globalipmatters.com/2017/05/17/amgen-sues-coherus-under-bpcia-after-completing-patent-dance\" target=\"_blank\">filed the complaint </a>in May after Coherus submitted a marketing application seeking approval for a biosimilar of Neulasta (pegfilgrastim).</li><li>Coherus expects a publicly available version of the Magistrate's report in ~two weeks.</li><li>Previously:&nbsp;<a href=\"https://seekingalpha.com/news/3272814-fda-rejects-coherus-marketing-application-neulasta-biosimilar-shares-34-percent-premarket\" target=\"_blank\">FDA rejects Coherus' marketing application for Neulasta biosimilar; shares down 34% premarket</a>&nbsp;(June 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3317269\" data-linked=\"Coherus to prevail in Amgen patent infringement suit; shares up 4%\" data-tweet=\"$AMGN $AMGN $CHRS - Coherus to prevail in Amgen patent infringement suit; shares up 4% https://seekingalpha.com/news/3317269-coherus-to-prevail-in-amgen-patent-infringement-suit-shares-up-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3317269-coherus-to-prevail-in-amgen-patent-infringement-suit-shares-up-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317271\" data-ts=\"1512753688\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DPW\" target=\"_blank\">DPW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317271-digital-power-down-16_5-after-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Digital Power down 16.5% after capital raise</a></h4><ul><li>Halted from trade all session, Digital Power (NYSEMKT:<a href='https://seekingalpha.com/symbol/DPW' title='DPW Holdings, Inc.'>DPW</a>) just resumed,&nbsp;<font color='red'>down 16.5%</font>.</li><li>The company minutes ago <a href=\"https://seekingalpha.com/pr/17022397-digital-power-corporation-announces-recent-developments\" target=\"_blank\">released details</a> on a number of transactions.</li><li>DPW prior to the open on Thursday <a href=\"https://seekingalpha.com/pr/17020755-digital-power-corporation-raises-2018-revenue-guidance-50-percent-prior-estimate\" target=\"_blank\">pushed out a press release</a> jacking 2018 revenue guidance by 50%. Caveat emptor.</li></ul><div class=\"tiny-share-widget\" data-id=\"3317271\" data-linked=\"Digital Power down 16.5% after capital raise\" data-tweet=\"$DPW - Digital Power down 16.5% after capital raise https://seekingalpha.com/news/3317271-digital-power-down-16_5-after-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3317271-digital-power-down-16_5-after-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317268\" data-ts=\"1512753222\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRVG\" target=\"_blank\">TRVG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317268-deutsche-bank-upgrades-trivago\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche Bank upgrades Trivago</a></h4><ul><li>        Deutsche Bank <a href=\"https://www.google.com/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=web&amp;cd=1&amp;cad=rja&amp;uact=8&amp;ved=0ahUKEwjWx-vr8_rXAhUl44MKHXGDCNwQFggnMAA&amp;url=https%3A%2F%2Fwww.streetinsider.com%2FAnalyst%2BComments%2FUPDATE%3A%2BDeutsche%2BBank%2BUpgrades%2Btrivago%2BN.V.%2B%28TRVG%29%2Bto%2BBuy%2BFollowing%2BAnalyst%2BDay%2F13582455.html&amp;usg=AOvVaw2vysZSsDoDS8ZUttchdjlZ\" target=\"_blank\">raises</a> its Trivago (NASDAQ:<a href='https://seekingalpha.com/symbol/TRVG' title='Trivago'>TRVG</a>) rating from Hold to Buy with a $10 price target.</li><li>               Analyst Lloyd Walmsley says Trivago should benefit as the bidding environment among large customers stabilizes.&nbsp;</li><li>               Trivago shares are&nbsp;<font color='green'>up 0.9%</font>. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3317268\" data-linked=\"Deutsche Bank upgrades Trivago\" data-tweet=\"$TRVG - Deutsche Bank upgrades Trivago https://seekingalpha.com/news/3317268-deutsche-bank-upgrades-trivago?source=tweet\" data-url=\"https://seekingalpha.com/news/3317268-deutsche-bank-upgrades-trivago\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317267\" data-ts=\"1512752495\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317267-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ADOM' title='ADOMANI, Inc.'>ADOM</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/FTFT' title='Future Fintech Group Inc'>FTFT</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/VRS' title='Verso Corporation'>VRS</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/VNCE' title='Vince Holding Corp.'>VNCE</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/FORD' title='Forward Industries, Inc.'>FORD</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/JOUT' title='Johnson Outdoors Inc.'>JOUT</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/FIZZ' title='National Beverage Corp.'>FIZZ</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/DTEA' title='DAVIDs TEA'>DTEA</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/FUV' title='Arcimoto, Inc.'>FUV</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3317267\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$ADOM $FTFT $VRS - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3317267-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3317267-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317265\" data-ts=\"1512752324\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IR\" target=\"_blank\">IR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317265-ingersoll-rand-upgraded-to-buy-goldman\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ingersoll-Rand upgraded to Buy at Goldman</a></h4><ul>     <li>Ingersoll-Rand (<a href='https://seekingalpha.com/symbol/IR' title='Ingersoll-Rand plc'>IR</a> <font color='green'>+1%</font>) is higher after Goldman Sachs <a href=\"https://thefly.com/thestreet/realmoney/index.php/IRid2652258/IR-IngersollRand-upgraded-to-Buy-from-Neutral-at-Goldman-Sachs\" target=\"_blank\">upgrades shares to Buy</a> from Neutral with a $100 price target, as analyst Joseph Ritchie calls the stock is his favorite value idea for 2018.</li>     <li>Ritchie is positive on the Americas multi-Industry space for 2018 due to capital expenditure growth and tax reform, which the firm believes could drive investment and improve margins.</li>     <li>Goldman also initiates Kratos Defense (<a href='https://seekingalpha.com/symbol/KTOS' title='Kratos Defense & Security Solutions, Inc.'>KTOS</a> <font color='red'>-4.2%</font>) with a <a href=\"https://thefly.com/thestreet/realmoney/index.php/KTOSid2652254/KTOS-Kratos-Defense-initiated-with-a-Neutral-at-Goldman-Sachs\" target=\"_blank\">Neutral rating</a>, saying a mixed operating track record along with valuation offset the company's top-line potential.</li></ul><div class=\"tiny-share-widget\" data-id=\"3317265\" data-linked=\"Ingersoll-Rand upgraded to Buy at Goldman\" data-tweet=\"$IR $IR $KTOS - Ingersoll-Rand upgraded to Buy at Goldman https://seekingalpha.com/news/3317265-ingersoll-rand-upgraded-to-buy-goldman?source=tweet\" data-url=\"https://seekingalpha.com/news/3317265-ingersoll-rand-upgraded-to-buy-goldman\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317261\" data-ts=\"1512750938\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DNLI\" target=\"_blank\">DNLI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317261-denali-therapeutics-strong-out-of-blocks-up-14\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Denali Therapeutics strong out of the blocks, up 14%</a></h4><ul><li>Denali Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/DNLI' title='Denali Therapeutics, Inc.'>DNLI</a>) is up&nbsp;<font color='green'>14%</font>&nbsp;on turnover of 2M shares in its U.S. debut. Shares are currently changing hands at ~$20.50 versus the $18 offer price.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3317045-denali-upsizes-ipo-250m\" target=\"_blank\">Denali upsizes IPO to $250M</a> (Dec. 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3317261\" data-linked=\"Denali Therapeutics strong out of the blocks, up 14%\" data-tweet=\"$DNLI - Denali Therapeutics strong out of the blocks, up 14% https://seekingalpha.com/news/3317261-denali-therapeutics-strong-out-of-blocks-up-14?source=tweet\" data-url=\"https://seekingalpha.com/news/3317261-denali-therapeutics-strong-out-of-blocks-up-14\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317260\" data-ts=\"1512750785\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCG\" target=\"_blank\">SCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317260-scana-rises-on-takeover-rumors-nextera-potential-suitor\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Scana rises on takeover rumors, with NextEra a potential suitor</a></h4><ul>     <li>Scana (<a href='https://seekingalpha.com/symbol/SCG' title='SCANA Corporation'>SCG</a> <font color='green'>+2.2%</font>) is moving higher on <a href=\"https://www.fitsnews.com/2017/12/08/nukegate-scana-sale-rumors-rampant/\" target=\"_blank\">rumors that the company is about to be sold</a>, possibly to NextEra Energy (<a href='https://seekingalpha.com/symbol/NEE' title='NextEra Energy, Inc.'>NEE</a> <font color='red'>-0.1%</font>), the Florida-based company that is said to be submitting a serious offer to buy South Carolina's state-run energy utility Santee Cooper; meanwhile, SCG&rsquo;s natural gas assets reportedly would be sold to Dominion Energy (<a href='https://seekingalpha.com/symbol/D' title='Dominion Energy, Inc.'>D</a> <font color='red'>-0.3%</font>).</li><li>The moves could make sense: Dominion is \"expanding its gas footprint,&rdquo; NEE has &ldquo;a voracious appetite for electric utility acquisition,&rdquo; and SCG is seeking survival after its failed nuclear project in the state, an unnamed analyst tells Fitsnews.com.</li><li>Reports <a href=\"https://seekingalpha.com/news/3315127-report-scana-hires-bank-consider-possible-sale\" target=\"_blank\">last week</a> said South Carolina's governor was seeking to sell Santee Cooper to potentially interested buyers including NEE, D, Duke Energy or Southern Co.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3317260\" data-linked=\"Scana rises on takeover rumors, with NextEra a potential suitor\" data-tweet=\"$SCG $SCG $NEE - Scana rises on takeover rumors, with NextEra a potential suitor https://seekingalpha.com/news/3317260-scana-rises-on-takeover-rumors-nextera-potential-suitor?source=tweet\" data-url=\"https://seekingalpha.com/news/3317260-scana-rises-on-takeover-rumors-nextera-potential-suitor\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317256\" data-ts=\"1512750616\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDUS\" target=\"_blank\">RDUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317256-radius-healths-elacestrant-shows-positive-effect-in-early-stage-breast-cancer-study-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Radius Health&#39;s elacestrant shows positive effect in early-stage breast cancer study; shares ahead 15%</a></h4><ul><li>Radius Health (<a href='https://seekingalpha.com/symbol/RDUS' title='Radius Health, Inc.'>RDUS</a> <font color='green'>+15%</font>) is up on 50% higher volume on the heels of its <a href=\"https://seekingalpha.com/pr/17021966-radius-investigational-drug-elacestrant-rad1901-continues-show-promise-advanced-er-her2\" target=\"_blank\">announcement </a>of positive results from a Phase 1 clinical trial assessing elacestrant (RAD1901) in estrogen receptor-positive (ER+) breast cancer. The data were presented at the San Antonio Breast Cancer Symposium.</li><li>In 22 patients with measurable disease, the response rate was 27% (n=6/22), all partial responders.</li><li>On the safety front, elacestrant was well-tolerated with most adverse events being low-grade nausea, vomiting and indigestion.</li><li>The company plans to launch a Phase 2 study in ER+/HER2- breast cancer next quarter. It will no longer evaluate it for vasomotor symptoms.</li><li><a href=\"https://radiuspharm.com/pipeline/\" target=\"_blank\">Elacestrant </a>is an orally available <a href=\"https://en.wikipedia.org/wiki/Selective_estrogen_receptor_degrader\" target=\"_blank\">estrogen receptor degrader</a> (down-regulator).</li></ul><div class=\"tiny-share-widget\" data-id=\"3317256\" data-linked=\"Radius Health&#39;s elacestrant shows positive effect in early-stage breast cancer study; shares ahead 15%\" data-tweet=\"$RDUS - Radius Health&#39;s elacestrant shows positive effect in early-stage breast cancer study; shares ahead 15% https://seekingalpha.com/news/3317256-radius-healths-elacestrant-shows-positive-effect-in-early-stage-breast-cancer-study-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3317256-radius-healths-elacestrant-shows-positive-effect-in-early-stage-breast-cancer-study-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317229\" data-ts=\"1512748910\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317229-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/NEPT' title='Neptune Wellness Solutions Inc.'>NEPT</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/RDUS' title='Radius Health, Inc.'>RDUS</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/APVO' title='Aptevo Therapeutics Inc.'>APVO</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/QHC' title='Quorum Health Corporation'>QHC</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/XENE' title='Xenon Pharmaceuticals'>XENE</a> <font color='green'>+13%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CGIX' title='Cancer Genetics, Inc.'>CGIX</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/LJPC' title='La Jolla Pharmaceutical Co.'>LJPC</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/VTGN' title='VistaGen Therapeutics, Inc.'>VTGN</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/ENZ' title='Enzo Biochem, Inc.'>ENZ</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/MRNS' title='Marinus Pharmaceuticals'>MRNS</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3317229\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$NEPT $RDUS $APVO - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3317229-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3317229-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317244\" data-ts=\"1512748019\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEVA\" target=\"_blank\">TEVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317244-teva-may-cut-many-10k-jobs-shares-up-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teva may cut as many as 10K jobs; shares up 6%</a></h4><ul><li>Aimed at shoring up its operations, Teva Pharmaceutical Industries (<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color='green'>+5.6%</font>) may eliminate as many as 10K positions Bloomberg <a href=\"https://www.bloomberg.com/news/articles/2017-12-08/teva-pharmaceutical-may-cut-up-to-10-000-jobs-globally\" target=\"_blank\">reports</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3314403-significant-action-needed-steady-company-teva\" target=\"_blank\">\"Significant action\" needed to steady company - Teva</a> (Nov. 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3317244\" data-linked=\"Teva may cut as many as 10K jobs; shares up 6%\" data-tweet=\"$TEVA - Teva may cut as many as 10K jobs; shares up 6% https://seekingalpha.com/news/3317244-teva-may-cut-many-10k-jobs-shares-up-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3317244-teva-may-cut-many-10k-jobs-shares-up-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>50&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317199\" data-ts=\"1512747623\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TOSBF\" target=\"_blank\">TOSBF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317199-nand-and-dram-prices-fall-on-week-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NAND and DRAM prices fall on the week (update)</a></h4><ul><li>NAND prices&nbsp;<font color='red'>fell 1.47%</font>&nbsp;in the past week. The six-week average is&nbsp;<font color='red'>down 0.55%</font>.</li><li>PC DRAM prices&nbsp;<font color='red'>fell 1.14%</font>&nbsp;in the week. The six-week average is&nbsp;<font color='green'>up 1.03%</font>.</li><li>Source: Bloomberg First Word.</li><li>Top NAND companies with <a href=\"https://www.statista.com/statistics/275886/market-share-held-by-leading-nand-flash-memory-manufacturers-worldwide/\" target=\"_blank\">Q3 market share</a>: Samsung (<a href='https://seekingalpha.com/symbol/TOSBF' title='Toshiba Corp.'>OTCPK:TOSBF</a>, <a href='https://seekingalpha.com/symbol/TOSYY' title='Toshiba Corp. ADR'>OTCPK:TOSYY</a>), 37.2%; Toshiba (<a href='https://seekingalpha.com/symbol/TOSBF' title='Toshiba Corp.'>OTCPK:TOSBF</a>, <a href='https://seekingalpha.com/symbol/TOSYY' title='Toshiba Corp. ADR'>OTCPK:TOSYY</a>), 17.5%; SanDisk/Western Digital (NYSE:<a href='https://seekingalpha.com/symbol/WDC' title='Western Digital Corporation'>WDC</a>), 17.5%; and Micron (NASDAQ:<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a>), 12.9%.</li><li>Top DRAM companies with <a href=\"https://www.statista.com/statistics/271725/global-dram-revenues-of-semiconductor-companies-since-2010/\" target=\"_blank\">Q3 market shares</a>: Samsung, 45.8%; SK Hynix, 28.7%; Micron, 21%.</li><li>Micron shares are&nbsp;<font color='green'>up 2.2%</font>&nbsp;premarket.</li><li>Western Digital shares are&nbsp;<font color='green'>up 1.6%</font>.</li><li>Update: In contrast to Bloomberg's data, DRAMeXchange has the average DRAM price up 1 cent and the NAND price down 2 cents.</li></ul><div class=\"tiny-share-widget\" data-id=\"3317199\" data-linked=\"NAND and DRAM prices fall on the week (update)\" data-tweet=\"$TOSBF $TOSBF $TOSYY - NAND and DRAM prices fall on the week (update) https://seekingalpha.com/news/3317199-nand-and-dram-prices-fall-on-week-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3317199-nand-and-dram-prices-fall-on-week-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>97&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317237\" data-ts=\"1512746286\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRTY\" target=\"_blank\">PRTY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317237-party-cityminus-10-after-large-secondary-offering-disclosed\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Party City -10% after large secondary offering disclosed</a></h4><ul> <li>Shares of Party City (NYSE:<a href='https://seekingalpha.com/symbol/PRTY' title='Party City Holdco, Inc.'>PRTY</a>) are <font color='red'>down 9.88%</font> after the company's secondary offering on the behalf of selling shareholders caught investors by surprise.</li> <li>Party City is buying back 2.5M shares out of the 10M being dumped. The company says it will use cash on hand and credit facility borrowings to make the purchases.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3317097-party-city-discloses-secondary-offering\" target=\"_blank\">Party City discloses secondary offering</a> (Dec. 7)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3317237\" data-linked=\"Party City -10% after large secondary offering disclosed\" data-tweet=\"$PRTY - Party City -10% after large secondary offering disclosed https://seekingalpha.com/news/3317237-party-cityminus-10-after-large-secondary-offering-disclosed?source=tweet\" data-url=\"https://seekingalpha.com/news/3317237-party-cityminus-10-after-large-secondary-offering-disclosed\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317230\" data-ts=\"1512745096\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYY\" target=\"_blank\">SYY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317230-wells-fargo-confident-on-sysco\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wells Fargo confident on Sysco</a></h4><ul> <li>Wells Fargo <a href=\"https://www.streetinsider.com/Analyst+PT+Change/Sysco+%28SYY%29+PT+Raised+to+%2467+at+Wells+Fargo+Following+Bullish+Analyst+Meeting/13582934.html\" target=\"_blank\">lifts</a> its price target on Sysco (NYSE:<a href='https://seekingalpha.com/symbol/SYY' title='Sysco Corporation'>SYY</a>) following what it calls a \"bullish analyst meeting\" this week.</li> <li>The food distributor set guidance on incremental EBIT to $650M-$700M through FY20 to top the prior Wells forecast.</li> <li>WF rates Sysco at Outperform and assigns a price target of $64. Shares of Sysco are up 7.5% since the analyst meeting.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3317230\" data-linked=\"Wells Fargo confident on Sysco\" data-tweet=\"$SYY - Wells Fargo confident on Sysco https://seekingalpha.com/news/3317230-wells-fargo-confident-on-sysco?source=tweet\" data-url=\"https://seekingalpha.com/news/3317230-wells-fargo-confident-on-sysco\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317223\" data-ts=\"1512743038\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STDY\" target=\"_blank\">STDY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317223-steadymed-up-34-premarket-on-pathway-for-resubmission-of-trevyent\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SteadyMed up 34% premarket on pathway for resubmission of Trevyent</a></h4><ul><li>Thinly traded nano cap SteadyMed (NASDAQ:<a href='https://seekingalpha.com/symbol/STDY' title='SteadyMed'>STDY</a>) is up&nbsp;<font color='green'>34%</font>&nbsp;premarket on robust volume in response to its <a href=\"https://seekingalpha.com/pr/17022102-steadymed-announces-fda-agreed-pathway-trevyent-nda-resubmission\" target=\"_blank\">announcement </a>that the FDA will not require any additional clinical trials to support its NDA resubmission for Trevyent for the treatment of pulmonary arterial hypertension &#40;PAH&#41;.</li><li>Per agency feedback, the company will need to repeat in vitro design verification testing on the final product, supported by pharmacokinetic modeling and process validation.</li><li>The application will be made under the 505(b)(2) pathway which allows the inclusion of data generated by others.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3292907-fda-rejects-steaymeds-marketing-application-lead-candidate-trevyent-pah-shares-28-percent\" target=\"_blank\">FDA rejects SteayMed's marketing application for lead candidate Trevyent for PAH; shares down 28% premarket</a> (Aug. 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3317223\" data-linked=\"SteadyMed up 34% premarket on pathway for resubmission of Trevyent\" data-tweet=\"$STDY - SteadyMed up 34% premarket on pathway for resubmission of Trevyent https://seekingalpha.com/news/3317223-steadymed-up-34-premarket-on-pathway-for-resubmission-of-trevyent?source=tweet\" data-url=\"https://seekingalpha.com/news/3317223-steadymed-up-34-premarket-on-pathway-for-resubmission-of-trevyent\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317222\" data-ts=\"1512742801\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AQMS\" target=\"_blank\">AQMS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317222-aqua-metals-prices-7_15m-share-offering-2_10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aqua Metals prices 7.15M-share offering at $2.10</a></h4><ul>     <li>Aqua Metals (NASDAQ:<a href='https://seekingalpha.com/symbol/AQMS' title='Aqua Metals'>AQMS</a>) <font color='red'>-19%</font> premarket after pricing a <a href=\"https://seekingalpha.com/pr/17022272-aqua-metals-prices-15-million-public-offering-common-stock\" target=\"_blank\">public offering</a> of 7.15M common shares at $2.10 each; the underwriter gets an option to purchase up to an additional ~1M shares.</li>     <li>AQMS <a href=\"https://seekingalpha.com/pr/17021801-aqua-metals-announces-proposed-public-offering-common-stock\" target=\"_blank\">plans to use the net proceeds</a> for working capital, which could include capex related to the expansion of production  activities at its initial AquaRefining facility in Nevada, and general corporate purposes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3317222\" data-linked=\"Aqua Metals prices 7.15M-share offering at $2.10\" data-tweet=\"$AQMS - Aqua Metals prices 7.15M-share offering at $2.10 https://seekingalpha.com/news/3317222-aqua-metals-prices-7_15m-share-offering-2_10?source=tweet\" data-url=\"https://seekingalpha.com/news/3317222-aqua-metals-prices-7_15m-share-offering-2_10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317221\" data-ts=\"1512742668\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317221-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/STDY' title='SteadyMed'>STDY</a> <font color='green'>+35%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/GLBS' title='Globus Maritime Ltd.'>GLBS</a> <font color='green'>+35%</font>&nbsp;on Q3 <a href=\"https://seekingalpha.com/news/3317069\" target=\"_blank\">earning</a>.</li>     <li><a href='https://seekingalpha.com/symbol/SIGM' title='Sigma Designs, Inc.'>SIGM</a>&nbsp;<font color='green'>+23%</font>&nbsp;on merger <a href=\"https://seekingalpha.com/news/3317181-sigma-designs-announces-merger-termination-fee\" target=\"_blank\">termination</a> fee.</li>     <li><a href='https://seekingalpha.com/symbol/DCIX' title='Diana Containerships Inc.'>DCIX</a> <font color='green'>+13%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/TRVG' title='Trivago'>TRVG</a> <font color='green'>+12%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/PXS' title='Pyxis Tankers Inc.'>PXS</a> <font color='green'>+10%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/CBIO' title='Catalyst Biosciences, Inc.'>CBIO</a> <font color='green'>+9%</font>&nbsp;on positive analyst <a href=\"https://seekingalpha.com/news/3317179-premarket-analyst-action-healthcare\" target=\"_blank\">action</a>.</li>     <li><a href='https://seekingalpha.com/symbol/CLDR' title='Cloudera, Inc.'>CLDR</a> <font color='green'>+8%</font>&nbsp;on Q3 <a href=\"https://seekingalpha.com/news/3317066-cloudera-beats-0_07-beats-revenue\" target=\"_blank\">earning</a>.</li>     <li><a href='https://seekingalpha.com/symbol/SHIP' title='Seanergy Maritime Holdings Corp'>SHIP</a> <font color='green'>+8%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/ALXN' title='Alexion Pharmaceuticals, Inc.'>ALXN</a> <font color='green'>+7%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3317139-alexion-plus-2_6-percent-report-elliott-taken-activist-stake\" target=\"_blank\">report</a> Elliott has taken activist stake.</li>     <li><a href='https://seekingalpha.com/symbol/HMY' title='Harmony Gold Mining Company Limited'>HMY</a> <font color='green'>+6%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/OLED' title='Universal Display Corporation'>OLED</a> <font color='green'>+6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3317114-universal-display-announces-oled-agreement-boe-technology\" target=\"_blank\">agreement</a> with BOE Technology.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3317221\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$STDY $GLBS $SIGM - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3317221-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3317221-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317220\" data-ts=\"1512742592\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317220-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/AQMS' title='Aqua Metals'>AQMS</a> <font color='red'>-21%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17021801-aqua-metals-announces-proposed-public-offering-common-stock\" target=\"_blank\">announcing</a> proposed public offering of common stock.</li><li><a href='https://seekingalpha.com/symbol/VECO' title='Veeco Instruments Inc.'>VECO</a> <font color='red'>-16%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17021779-veeco-provides-update-patent-litigation\" target=\"_blank\">providing</a> update on its two patent infringement lawsuits.</li><li><a href='https://seekingalpha.com/symbol/AOBC' title='American Outdoor Brands Corporation'>AOBC</a>&nbsp;<font color='red'>-16%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3317191-firearms-sector-watch-american-outdoor-print-house-vote\" target=\"_blank\">announcing</a> cut in guidance.</li><li><a href='https://seekingalpha.com/symbol/TELL' title='Tellurian Inc.'>TELL</a>&nbsp;<font color='red'>-15%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3317132-tellurian-launch-8m-share-offering\" target=\"_blank\">announcing</a> a public offering of 8M common shares.</li><li><a href='https://seekingalpha.com/symbol/LJPC' title='La Jolla Pharmaceutical Co.'>LJPC</a>&nbsp;<font color='red'>-11%</font>&nbsp;on being <a href=\"https://seekingalpha.com/news/3317214-jp-morgan-bearish-la-jolla-doctor-feedback-planned-pricing-ljpcminus-501-sees-38-percent\" target=\"_blank\">downgraded</a> to Underweight by JP Morgan.</li><li><a href='https://seekingalpha.com/symbol/VTGN' title='VistaGen Therapeutics, Inc.'>VTGN</a> <font color='red'>-6%</font>.</li><li><a href='https://seekingalpha.com/symbol/PRTY' title='Party City Holdco, Inc.'>PRTY</a>&nbsp;<font color='red'>-5%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3317097-party-city-discloses-secondary-offering\" target=\"_blank\">announcing</a>&nbsp;a secondary offering of 10M shares.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3317220\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$AQMS $VECO $AOBC - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3317220-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3317220-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317212\" data-ts=\"1512741344\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYNA\" target=\"_blank\">SYNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317212-oppenheimer-upgrades-synaptics\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oppenheimer upgrades Synaptics</a></h4><ul><li>        Oppenheimer <a href=\"http://www.briefing.com/DisplayArticle/ArticlePopup.aspx?ArticleId=IN20171208070321SYNA\" target=\"_blank\">upgrades</a> Synaptics (NASDAQ:<a href='https://seekingalpha.com/symbol/SYNA' title='Synaptics Incorporated'>SYNA</a>) from Underperform to Perform.</li><li>               Synaptics shares are&nbsp;<font color='green'>up 4.9%</font>&nbsp;premarket.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3313335-synaptics-announces-job-cuts\" target=\"_blank\">Synaptics announces job cuts</a> (Nov. 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3317212\" data-linked=\"Oppenheimer upgrades Synaptics\" data-tweet=\"$SYNA - Oppenheimer upgrades Synaptics https://seekingalpha.com/news/3317212-oppenheimer-upgrades-synaptics?source=tweet\" data-url=\"https://seekingalpha.com/news/3317212-oppenheimer-upgrades-synaptics\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317209\" data-ts=\"1512741001\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GDDY\" target=\"_blank\">GDDY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317209-wedbush-initiates-godaddy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wedbush initiates GoDaddy</a></h4><ul><li>        Wedbush <a href=\"http://www.briefing.com/DisplayArticle/ArticlePopup.aspx?ArticleId=IN20171208071614GDDY\" target=\"_blank\">initiates</a> GoDaddy (NYSE:<a href='https://seekingalpha.com/symbol/GDDY' title='GoDaddy Inc.'>GDDY</a>) with a Neutral rating and $52 price target.</li><li>                  GoDaddy shares are&nbsp;<font color='green'>up 4.9%</font>&nbsp;premarket.&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3316353-godaddy-prices-common-stock-offering\" target=\"_blank\">GoDaddy prices common stock offering</a> (Dec. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3317209\" data-linked=\"Wedbush initiates GoDaddy\" data-tweet=\"$GDDY - Wedbush initiates GoDaddy https://seekingalpha.com/news/3317209-wedbush-initiates-godaddy?source=tweet\" data-url=\"https://seekingalpha.com/news/3317209-wedbush-initiates-godaddy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317207\" data-ts=\"1512740700\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CIEN\" target=\"_blank\">CIEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317207-piper-jaffray-downgrades-ciena\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Piper Jaffray downgrades Ciena</a></h4><ul><li>        Piper Jaffray <a href=\"https://www.google.com/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=web&amp;cd=2&amp;cad=rja&amp;uact=8&amp;ved=0ahUKEwiiq_mMxfrXAhUk1oMKHVLEDhEQFggtMAE&amp;url=https%3A%2F%2Fwww.streetinsider.com%2FAnalyst%2BComments%2FPiper%2BJaffray%2BDowngrades%2BCIENA%2B%28CIEN%29%2Bto%2BNeutral%2F13582422.html&amp;usg=AOvVaw2LyBxMOZ-NoQU4RVFiny5e\" target=\"_blank\">downgrades</a> Ciena (NASDAQ:<a href='https://seekingalpha.com/symbol/CIEN' title='Ciena Corporation'>CIEN</a>) from Overweight to Neutral and lowers the price target from $29 to $22.</li><li>               Analyst Troy Jensen sees challenges in the company&rsquo;s growth targets due to competitive pressure.&nbsp;</li><li>               Ciena shares are&nbsp;<font color='red'>down 0.58%</font>&nbsp;premarket.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3316894-ciena-plus-5_8-percent-mixed-q4-results-share-repurchase-program\" target=\"_blank\">Ciena +5.8% after mixed Q4 results, share repurchase program</a> (Dec. 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3317207\" data-linked=\"Piper Jaffray downgrades Ciena\" data-tweet=\"$CIEN - Piper Jaffray downgrades Ciena https://seekingalpha.com/news/3317207-piper-jaffray-downgrades-ciena?source=tweet\" data-url=\"https://seekingalpha.com/news/3317207-piper-jaffray-downgrades-ciena\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317198\" data-ts=\"1512740567\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLNO\" target=\"_blank\">SLNO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317198-soleno-up-16-premarket-on-move-away-from-capnia\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Soleno up 16% premarket on move away from Capnia</a></h4><ul><li>Soleno Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SLNO' title='Soleno Therapeutics, Inc.'>SLNO</a>) and wholly owned subsidiary Capnia ink a joint venture <a href=\"https://seekingalpha.com/pr/17022172-soleno-therapeutics-announces-joint-venture-agreement-development-commercialization-cosense\" target=\"_blank\">agreement </a>with Hong Kong-based OptAsia Healthcare Limited &#40;OAHL&#41; to develop and commercialize Capnia's Sensalyze technology, including the CoSense End-Tidal Carbon Monoxide monitor.</li><li>Under the terms of the agreement, OAHL will make up to a $2.2M equity investment in Capnia (NASDAQ:<a href='https://seekingalpha.com/symbol/CAPN' title='Capnia'>CAPN</a>) which means that it will no longer be a wholly-owned subsidiary of Soleno. Henceforward, OAHL will fund Capnia's operations. OAHL also has the option of acquiring the rest of Capnia at a value based on revenue.</li><li>Soleno says the deal will enable it to sharpen its focus on developing rare disease therapeutics. Lead candidate is once-daily tablet diazoxide choline for Prader-Willi syndrome.</li><li>SLNO is up&nbsp;<font color='green'>16%</font>&nbsp;premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3317198\" data-linked=\"Soleno up 16% premarket on move away from Capnia\" data-tweet=\"$SLNO $SLNO $CAPN - Soleno up 16% premarket on move away from Capnia https://seekingalpha.com/news/3317198-soleno-up-16-premarket-on-move-away-from-capnia?source=tweet\" data-url=\"https://seekingalpha.com/news/3317198-soleno-up-16-premarket-on-move-away-from-capnia\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317205\" data-ts=\"1512740456\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317205-treasury-yields-move-higher-after-jobs-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Treasury yields move higher after jobs beat</a></h4><ul><li>The U.S. added 228K jobs in November, besting estimates by 28K. October's 261Kk gain was revised down to 244K, and September's 18K up to 38K. We'll call revisions a wash.</li><li>The unemployment rate was flat at 4.1%, as was the labor force participation rate at 62.7%. The broader U-6 unemployment rose ticked up to 8% in November.</li><li>The average workweek edged higher to 34.5 hours. Average hourly earnings rose a nickel to $26.55; on a year-over-year basis, they're up 2.5%.</li><li>The 10-year Treasury yield has moved up a couple of basis points since the report hit, now at 2.39%. <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a>&nbsp;<font color='red'>-0.4%</font>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a>&nbsp;<font color='green'>+0.8%</font>.</li><li>Gold (NYSEARCA:<a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a>) remains down a hair, and the dollar (NYSEARCA:<a href='https://seekingalpha.com/symbol/UUP' title='PowerShares DB USD Bull ETF'>UUP</a>) modestly higher.</li><li>Stock index futures also remain modestly higher, led by the Nasdaq 100's&nbsp;<font color='green'>0.5% advance</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3317200-228k-jobs-added-november-ue-rate-stable-4_1-percent\" target=\"_blank\">228K jobs added in November; UE rate stable at 4.1%</a> (Dec. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3317205\" data-linked=\"Treasury yields move higher after jobs beat\" data-tweet=\"$TLT $TBT $GLD - Treasury yields move higher after jobs beat https://seekingalpha.com/news/3317205-treasury-yields-move-higher-after-jobs-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3317205-treasury-yields-move-higher-after-jobs-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317201\" data-ts=\"1512739845\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317201-metals-stocks-move-up-china-s-commodity-demand-picks-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Metals stocks move up as China\u2019s commodity demand picks up</a></h4><ul>     <li>Metals stocks are mostly higher after <a href=\"https://seekingalpha.com/news/3317149-trade-data-china\" target=\"_blank\">China reported exports surged 12.3%</a> in November from a year ago, more than double expectations, and imports climbed 17.7%; <a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color='green'>+1.5%</font>, <a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a> <font color='green'>+1.3%</font>, <a href='https://seekingalpha.com/symbol/BHP' title='BHP Billiton Limited'>BHP</a> <font color='green'>+1.2%</font>, <a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a> <font color='green'>+0.9%</font>, <a href='https://seekingalpha.com/symbol/FCX' title='Freeport-McMoRan Inc.'>FCX</a> <font color='green'>+0.8%</font>, <a href='https://seekingalpha.com/symbol/RIO' title='Rio Tinto plc'>RIO</a> flat in premarket trade.</li>     <li>China&rsquo;s <a href=\"https://www.ft.com/content/0a111190-b23b-33af-bc79-d28e7017fe88\" target=\"_blank\">demand for commodities jumped</a>, as the world&rsquo;s largest consumer of raw materials saw higher imports of copper, crude oil and iron ore; shipments of copper soared 42%, iron ore jumped 19%, and imports of crude oil hit 9.04M bbl/day, their second highest recorded level ever.</li>     <li>Traders say the import data should help support commodity prices, which have been hit by concerns about slowing economic growth in China.</li><li>Jefferies analysts say sharp declines in Chinese finished steel exports show improved supply-side discipline while low inventories and strong prices and margins further <a href=\"https://twitter.com/thenotablecalls/status/939106825147944960\" target=\"_blank\">highlight market tightness</a>; the firm says ArcelorMittal (NYSE:<a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a>) is its sector favorite.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/JJC' title='iPath Series B Bloomberg Copper Subindex Total Return ETN'>JJC</a>, <a href='https://seekingalpha.com/symbol/DBB' title='Invesco DB Base Metals ETF'>DBB</a>, <a href='https://seekingalpha.com/symbol/JJN' title='iPath DJ-UBS Nickel Total Return Sub-Index ETN'>JJN</a>, <a href='https://seekingalpha.com/symbol/CPER' title='United States Copper Index ETF'>CPER</a>, <a href='https://seekingalpha.com/symbol/JJU-OLD' title='iPath Dow Jones-UBS Aluminum Total Return Sub-IndexS ETN'>JJU-OLD</a>, <a href='https://seekingalpha.com/symbol/BOM' title='DB Base Metals Double Short ETN'>BOM</a>, <a href='https://seekingalpha.com/symbol/BOS' title='DB Base Metals Short ETN'>BOS</a>, <a href='https://seekingalpha.com/symbol/NINI' title='iPath Pure Beta Nickel ETN'>NINI</a>, <a href='https://seekingalpha.com/symbol/JJM' title='iPath DJ-UBS Industrial Metals Total Return Sub-Index ETN'>JJM</a>, <a href='https://seekingalpha.com/symbol/CUPM' title='iPath Pure Beta Copper ETN'>CUPM</a>, <a href='https://seekingalpha.com/symbol/BDD' title='DB Base Metals Double Long ETN'>BDD</a>, <a href='https://seekingalpha.com/symbol/FOIL' title='iPath Pure Beta Aluminum ETN'>FOIL</a>, <a href='https://seekingalpha.com/symbol/RJZ' title='ELEMENTS Rogers International Commodity Metal ETN'>RJZ</a>, <a href='https://seekingalpha.com/symbol/BDG-OLD' title='DB Base Metals Long ETN'>BDG-OLD</a>, <a href='https://seekingalpha.com/symbol/UBM' title='UBS ETRACS CMCI Industrial Metals Total Return ETN'>UBM</a>, <a href='https://seekingalpha.com/symbol/HEVY' title='iPath Pure Beta Industrial Metals ETN'>HEVY</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3317201\" data-linked=\"Metals stocks move up as China\u2019s commodity demand picks up\" data-tweet=\"$X $X $VALE - Metals stocks move up as China\u2019s commodity demand picks up https://seekingalpha.com/news/3317201-metals-stocks-move-up-china-s-commodity-demand-picks-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3317201-metals-stocks-move-up-china-s-commodity-demand-picks-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317196\" data-ts=\"1512739334\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBTC\" target=\"_blank\">GBTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317196-bitcoin-worrying-whales-coinbase-becomes-1-app\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More Bitcoin: Worrying about the whales; Coinbase becomes #1 app</a></h4><ul><li>Above the fold <a href=\"https://www.bloomberg.com/news/articles/2017-12-08/the-bitcoin-whales-1-000-people-who-own-40-percent-of-the-market\" target=\"_blank\">on Bloomberg this morning</a> is what's apparently meant to be a cautionary tale about the Bitcoin Whales. According to the story, about 40% of the crypto is held by maybe 1K users.</li><li>What if they collude, or what if they all decide to sell at once, worries the author. Sounds pretty much any other asset class. A wise trader (Paul Tudor Jones?) once said, when you own that much of the market, you are the market.</li><li>Others looking for bell-ringing news will find it in Coinbase. The crypto exchange's app <a href=\"https://www.recode.net/2017/12/7/16749536/coinbase-bitcoin-most-downloaded-app-iphone\" target=\"_blank\">has moved from</a> barely visible in the rankings to the most-downloaded iPhone app in the country. Yesterday's frenzied action in Bitcoin crashed the Coinbase site.</li><li>Bitcoin continues to head lower, now&nbsp;<font color='red'>down 13.5%</font>&nbsp;to $14,580.</li><li>Related tickers: <a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a>, <a href='https://seekingalpha.com/symbol/COIN' title='Winklevoss Bitcoin Trust ETF'>COIN</a>, <a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>, <a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a>, <a href='https://seekingalpha.com/symbol/SSC-OLD' title='Seven Stars Cloud Group, Inc.'>SSC-OLD</a>, <a href='https://seekingalpha.com/symbol/MARA' title='Marathon Patent Group, Inc.'>MARA</a>, <a href='https://seekingalpha.com/symbol/UEPS' title='Net 1 UEPS Technologies, Inc.'>UEPS</a>, <a href='https://seekingalpha.com/symbol/BITCF' title='First Bitcoin Capital Corp.'>OTC:BITCF</a>, <a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a>, <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a>, <a href='https://seekingalpha.com/symbol/BTSC' title='Bitcoin Services, Inc.'>OTCPK:BTSC</a>, <a href='https://seekingalpha.com/symbol/BTCS' title='BTCS Inc.'>OTCQB:BTCS</a>, <a href='https://seekingalpha.com/symbol/MGTI' title='MGT Capital Investments, Inc.'>OTCQB:MGTI</a>, <a href='https://seekingalpha.com/symbol/SRAX' title='Social Reality Inc.'>SRAX</a>, <a href='https://seekingalpha.com/symbol/GAHC' title='Global Arena Holding, Inc.'>OTCPK:GAHC</a>, <a href='https://seekingalpha.com/symbol/UBIA' title='UBI BlockChain Internet Ltd.'>OTC:UBIA</a>, <a href='https://seekingalpha.com/symbol/ARSC' title='American Security Resources Corp.'>OTC:ARSC</a>, <a href='https://seekingalpha.com/symbol/USTC' title='USA Real Estate Holding Co'>OTCPK:USTC</a>, PRELF, <a href='https://seekingalpha.com/symbol/BLKCF' title='Global Blockchain Technologies Corp.'>OTCPK:BLKCF</a>, <a href='https://seekingalpha.com/symbol/CRCW' title='The Crypto Company'>OTC:CRCW</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3317196\" data-linked=\"More Bitcoin: Worrying about the whales; Coinbase becomes #1 app\" data-tweet=\"$GBTC $GBTC $COIN - More Bitcoin: Worrying about the whales; Coinbase becomes #1 app https://seekingalpha.com/news/3317196-bitcoin-worrying-whales-coinbase-becomes-1-app?source=tweet\" data-url=\"https://seekingalpha.com/news/3317196-bitcoin-worrying-whales-coinbase-becomes-1-app\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>79&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317195\" data-ts=\"1512739267\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDXC\" target=\"_blank\">CDXC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317195-chromadex-up-8-premarket-on-promising-research-on-nicotinamide-riboside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chromadex up 8% premarket on promising research on nicotinamide riboside</a></h4><ul><li>Thinly traded micro cap Chromadex (NASDAQ:<a href='https://seekingalpha.com/symbol/CDXC' title='ChromaDex Inc.'>CDXC</a>) is up&nbsp;<font color='green'>8%</font>&nbsp;premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17022086-nicotinamide-riboside-shown-improve-mitochondrial-energy-production-memory-alzheimer-s\" target=\"_blank\">announcement </a>of encouraging research data on vitamin nicotinamide riboside &#40;NR&#41; in a mouse model of Alzheimer's disease &#40;AD&#41;. The results were just published in the journal <em>Nature</em>.</li><li>The data showed AD mice treated with NR showed lower levels of amyloid deposits, improved mitochondrial energy production and improved memory.</li><li>NR was discovered by Chromadex Chief Scientific Advisor Dr. Charles Brenner and is being developed by the company.</li></ul><div class=\"tiny-share-widget\" data-id=\"3317195\" data-linked=\"Chromadex up 8% premarket on promising research on nicotinamide riboside\" data-tweet=\"$CDXC - Chromadex up 8% premarket on promising research on nicotinamide riboside https://seekingalpha.com/news/3317195-chromadex-up-8-premarket-on-promising-research-on-nicotinamide-riboside?source=tweet\" data-url=\"https://seekingalpha.com/news/3317195-chromadex-up-8-premarket-on-promising-research-on-nicotinamide-riboside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317191\" data-ts=\"1512738414\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AOBC\" target=\"_blank\">AOBC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317191-firearms-sector-on-watch-after-american-outdoor-print-house-vote\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Firearms sector on watch after American Outdoor print, House vote</a></h4><ul> <li>American Outdoor Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/AOBC' title='American Outdoor Brands Corporation'>AOBC</a>) is lower in early action after cutting its revenue and EPS forecast for the full year due to challenging market conditions.</li> <li>The cut in guidance was the second of the year for AOBC and included a signal of sustained lower firearms demand from some retail channels.</li> <li>The gun sector was boosted yesterday before American Outdoor spilled its numbers by the House of Representatives approval of a bill that loosens some concealed carry regulations along with tighter instant criminal background checks records.</li> <li>AOBC <font color='red'>-15.5% </font>premarket, keep an eye on Sportsman's Warehouse (NASDAQ:<a href='https://seekingalpha.com/symbol/SPWH' title='Sportsman&#39;s Warehouse Holdings, Inc.'>SPWH</a>), Sturm Ruger (NYSE:<a href='https://seekingalpha.com/symbol/RGR' title='Sturm, Ruger & Company Inc.'>RGR</a>) and Vista Outdoors (NYSE:<a href='https://seekingalpha.com/symbol/VSTO' title='Vista Outdoor'>VSTO</a>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3317191\" data-linked=\"Firearms sector on watch after American Outdoor print, House vote\" data-tweet=\"$AOBC $AOBC $SPWH - Firearms sector on watch after American Outdoor print, House vote https://seekingalpha.com/news/3317191-firearms-sector-on-watch-after-american-outdoor-print-house-vote?source=tweet\" data-url=\"https://seekingalpha.com/news/3317191-firearms-sector-on-watch-after-american-outdoor-print-house-vote\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317183\" data-ts=\"1512738150\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ERYP\" target=\"_blank\">ERYP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317183-erytechs-lead-product-candidate-flunks-mid-stage-aml-study-shares-off-28-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ERYTECH&#39;s lead product candidate flunks mid-stage AML study; shares off 28% premarket</a></h4><ul> <li>Thinly traded micro cap ERYTECH Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ERYP' title='Erytech Pharma S.A. ADS'>ERYP</a>) slumps&nbsp;<font color='red'>28%</font>&nbsp;premarket in response to its <a href=\"https://seekingalpha.com/pr/17022029-erytech-reports-top-line-results-phase-2b-study-eryaspase-treatment-aml\" target=\"_blank\">announcement </a>that its&nbsp;Phase 2b clinical trial evaluating lead candidate GRASPA (eryaspase) for the treatment of acute myeloid leukemia &#40;AML&#41; failed to achieve the primary endpoint of overall survival.</li>                             <li>ERYTECH will hold a conference call and webcast on December 11&nbsp;at 10:00 am ET to discuss the data.</li><li>GRASPA is the enzyme L-asparaginase, a standard component of chemo for ALL, encapsulated inside donor-derived red blood cells. Its value proposition is a better tolerability profile versus non-encapsulated asparaginases.</li><li>Shares are down&nbsp;<font color='red'>28%</font>&nbsp;premarket on light volume.</li>                 </ul><div class=\"tiny-share-widget\" data-id=\"3317183\" data-linked=\"ERYTECH&#39;s lead product candidate flunks mid-stage AML study; shares off 28% premarket\" data-tweet=\"$ERYP - ERYTECH&#39;s lead product candidate flunks mid-stage AML study; shares off 28% premarket https://seekingalpha.com/news/3317183-erytechs-lead-product-candidate-flunks-mid-stage-aml-study-shares-off-28-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3317183-erytechs-lead-product-candidate-flunks-mid-stage-aml-study-shares-off-28-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317179\" data-ts=\"1512736826\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CKPT\" target=\"_blank\">CKPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317179-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Checkpoint Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CKPT' title='CHECKPOINT THERAPEUTICS'>CKPT</a>) initiated with Buy rating and $11 (139% upside) price target by H.C. Wainwright.</li><li>Catalyst Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/CBIO' title='Catalyst Biosciences, Inc.'>CBIO</a>) initiated with Buy rating and $19 (166% upside) price target by B. Riley FBR.</li><li>DENTSPLY SIRONA (NASDAQ:<a href='https://seekingalpha.com/symbol/XRAY' title='DENTSPLY SIRONA, Inc'>XRAY</a>) initiated with Buy rating and $81 (25% upside) price target by Deutsche Bank.</li><li>Teladoc (NYSE:<a href='https://seekingalpha.com/symbol/TDOC' title='Teladoc Health, Inc.'>TDOC</a>) initiated with Buy rating and $39 (16% upside) price target by Deutsche Bank.</li><li>Patterson Companies (NASDAQ:<a href='https://seekingalpha.com/symbol/PDCO' title='Patterson Companies Inc.'>PDCO</a>) initiated with Hold rating and $37 (5% upside) price target by Deutsche Bank.</li><li>Repligen (NASDAQ:<a href='https://seekingalpha.com/symbol/RGEN' title='Repligen Corporation'>RGEN</a>) initiated with Buy rating and $45 (30% upside) price target by Citigroup.</li><li>Athenahealth (NASDAQ:<a href='https://seekingalpha.com/symbol/ATHN' title='athenahealth, Inc.'>ATHN</a>) initiated with Hold rating by Deutsche Bank.</li><li>Align Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/ALGN' title='Align Technology, Inc.'>ALGN</a>) initiated with Hold rating by Deutsche Bank.</li><li>Medidata (NASDAQ:<a href='https://seekingalpha.com/symbol/MDSO' title='Medidata Solutions, Inc.'>MDSO</a>) initiated with Buy rating by Deutsche Bank.</li><li>Lipocine (NASDAQ:<a href='https://seekingalpha.com/symbol/LPCN' title='Lipocine Inc.'>LPCN</a>) resumed with Buy rating and $10 (190% upside) price target by H.C. Wainwright.</li><li>Boston Scientific (NYSE:<a href='https://seekingalpha.com/symbol/BSX' title='Boston Scientific Corporation'>BSX</a>) upgraded to Strong Buy by Needham.</li><li>Celgene (NASDAQ:<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a>) upgraded to Overweight by Atlantic Equities.</li><li>Perrigo (NASDAQ:<a href='https://seekingalpha.com/symbol/PRGO' title='Perrigo Company'>PRGO</a>) upgraded to Buy by Argus Research.</li><li>La Jolla Pharmaceutical (NASDAQ:<a href='https://seekingalpha.com/symbol/LJPC' title='La Jolla Pharmaceutical Co.'>LJPC</a>) downgraded to Underweight by JPMorgan.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3317179\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$CKPT $CKPT $CBIO - Premarket analyst action - healthcare https://seekingalpha.com/news/3317179-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3317179-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317181\" data-ts=\"1512736544\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIGM\" target=\"_blank\">SIGM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317181-sigma-designs-announces-merger-termination-fee\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sigma Designs announces merger termination fee</a></h4><ul><li>        Sigma Designs (NASDAQ:<a href='https://seekingalpha.com/symbol/SIGM' title='Sigma Designs, Inc.'>SIGM</a>) says it will pay a <a href=\"https://seekingalpha.com/filing/3792621\" target=\"_blank\">$11.5M termination fee</a> if the merger with Silicon Labs (NASDAQ:<a href='https://seekingalpha.com/symbol/SLAB' title='Silicon Laboratories, Inc.'>SLAB</a>) terminates under certain circumstances.</li><li>               Silicon Labs announced its planned acquisition of Sigma aftermarket yesterday.</li><li>               Sigma Designs shares are&nbsp;<font color='green'>up 24.1%</font>&nbsp;premarket.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3317123-silicon-labs-buy-sigma-designs-7_05-share\" target=\"_blank\">Silicon Labs to buy Sigma Designs for $7.05/share</a> (Dec. 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3317181\" data-linked=\"Sigma Designs announces merger termination fee\" data-tweet=\"$SIGM $SIGM $SLAB - Sigma Designs announces merger termination fee https://seekingalpha.com/news/3317181-sigma-designs-announces-merger-termination-fee?source=tweet\" data-url=\"https://seekingalpha.com/news/3317181-sigma-designs-announces-merger-termination-fee\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317180\" data-ts=\"1512736532\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LC\" target=\"_blank\">LC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317180-lendingclub-bull-stays-after-yesterdays-disappointment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LendingClub bull stays so after yesterday&#39;s disappointment</a></h4><ul><li>Guidance for Q4 of this year and all of next year was shy of hopes yesterday, sending LendingClub (NYSE:<a href='https://seekingalpha.com/symbol/LC' title='LendingClub Corporation'>LC</a>) tumbling 15.5%.</li><li>\"We find it remarkable that a reduced outlook due in large part to short-term adjustments to the company's credit model,\" would spook investors so much, <a href=\"http://researchwiseny.btig.com/ResearchLibraryAnalec/DownloadResearch.aspx?E=bahffk-b\" target=\"_blank\">says BTIG's Mark Palmer</a>, reiterating his Buy rating, but trimming the price target to $7 from $9 (still 100% upside from yesterday's close).</li><li>He notes banks - which fled LC's platform in wake the CEO resignation - have returned. Further, the company has diversified funding with successful loan securitizations, and approved more than 100M loan applications this year.</li><li>While LendingClub has tightened underwriting standards and thus reduced its near-term outlook, the future looks promising at a very cheap price, says Palmer.</li><li>Shares&nbsp;<font color='green'>+1.7%</font>&nbsp;premarket to $3.65.</li></ul><div class=\"tiny-share-widget\" data-id=\"3317180\" data-linked=\"LendingClub bull stays so after yesterday&#39;s disappointment\" data-tweet=\"$LC - LendingClub bull stays so after yesterday&#39;s disappointment https://seekingalpha.com/news/3317180-lendingclub-bull-stays-after-yesterdays-disappointment?source=tweet\" data-url=\"https://seekingalpha.com/news/3317180-lendingclub-bull-stays-after-yesterdays-disappointment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317175\" data-ts=\"1512735767\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HIMX\" target=\"_blank\">HIMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317175-himax-technologies-responds-to-citron-research-accusation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Himax Technologies responds to Citron Research accusation</a></h4><ul><li>        Himax Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/HIMX' title='Himax Technologies, Inc.'>HIMX</a>) <a href=\"https://seekingalpha.com/pr/17022057-himax-technologies-strongly-denies-citron-research-allegations-fraud\" target=\"_blank\">responds</a> to Citron Research&rsquo;s Wednesday tweet calling the company a fraud.</li><li>               Key quote: &ldquo;The Company reaffirms its commitment to transparent and reliable shareholder communication, and its adherence to the highest standards of corporate governance. Himax cautions investors that Citron Research has never made any contacts with the Company and that the tweet did not contain any input from the Company. Himax categorically denies any and all allegations of fraud.&rdquo;&nbsp;</li><li>Himax shares are&nbsp;<font color='green'>up 1.9%</font>&nbsp;premarket.&nbsp; &nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3316685-himax-minus-10_2-percent-citron-research-tweet\" target=\"_blank\">Himax -10.2% after Citron Research tweet</a> (Dec. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3317175\" data-linked=\"Himax Technologies responds to Citron Research accusation\" data-tweet=\"$HIMX - Himax Technologies responds to Citron Research accusation https://seekingalpha.com/news/3317175-himax-technologies-responds-to-citron-research-accusation?source=tweet\" data-url=\"https://seekingalpha.com/news/3317175-himax-technologies-responds-to-citron-research-accusation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>195&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3317173\" data-ts=\"1512735412\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBOE\" target=\"_blank\">CBOE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3317173-bitcoin-lower-11-ahead-of-futures-opening\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bitcoin lower by 11% ahead of futures opening</a></h4><ul><li>Bitcoin futures will become available for trade at the <a href='https://seekingalpha.com/symbol/CBOE' title='CBOE Holdings'>CBOE</a> on Sunday evening. After yesterday's wild ride which saw the crypto sky to nearly $20K (on some exchanges), it's&nbsp;<font color='red'>lower by 11%</font>&nbsp;this morning to just under $15K.</li><li>Alt coins - which had almost uniformly headed lower this week amid Bitcoin's surge - are mostly in the green. Ether is&nbsp;<font color='green'>up 5%</font>&nbsp;and Litecoin&nbsp;<font color='green'>3%</font>.</li><li>Meanwhile, <a href=\"https://www.coindesk.com/report-bitcoin-derivatives-banned-south-korean-government/\" target=\"_blank\">Coindesk is reporting</a> that South Korean regulators have apparently banned futures contracts and other derivatives tied to Bitcoin.</li><li>\"Please invest responsibly,\" <a href=\"https://blog.coinbase.com/please-invest-responsibly-an-important-message-from-the-coinbase-team-bf7f13a4b0b1\" target=\"_blank\">writes the chief of Coinbase </a>in a blog post this morning.</li><li>Related tickers: <a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a>, <a href='https://seekingalpha.com/symbol/COIN' title='Winklevoss Bitcoin Trust ETF'>COIN</a>, <a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>, <a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a>, <a href='https://seekingalpha.com/symbol/SSC-OLD' title='Seven Stars Cloud Group, Inc.'>SSC-OLD</a>, <a href='https://seekingalpha.com/symbol/MARA' title='Marathon Patent Group, Inc.'>MARA</a>, <a href='https://seekingalpha.com/symbol/UEPS' title='Net 1 UEPS Technologies, Inc.'>UEPS</a>, <a href='https://seekingalpha.com/symbol/BITCF' title='First Bitcoin Capital Corp.'>OTC:BITCF</a>, <a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a>, <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a>, <a href='https://seekingalpha.com/symbol/BTSC' title='Bitcoin Services, Inc.'>OTCPK:BTSC</a>, <a href='https://seekingalpha.com/symbol/BTCS' title='BTCS Inc.'>OTCQB:BTCS</a>, <a href='https://seekingalpha.com/symbol/MGTI' title='MGT Capital Investments, Inc.'>OTCQB:MGTI</a>, <a href='https://seekingalpha.com/symbol/SRAX' title='Social Reality Inc.'>SRAX</a>, <a href='https://seekingalpha.com/symbol/GAHC' title='Global Arena Holding, Inc.'>OTCPK:GAHC</a>, <a href='https://seekingalpha.com/symbol/UBIA' title='UBI BlockChain Internet Ltd.'>OTC:UBIA</a>, <a href='https://seekingalpha.com/symbol/ARSC' title='American Security Resources Corp.'>OTC:ARSC</a>, <a href='https://seekingalpha.com/symbol/USTC' title='USA Real Estate Holding Co'>OTCPK:USTC</a>, PRELF, <a href='https://seekingalpha.com/symbol/BLKCF' title='Global Blockchain Technologies Corp.'>OTCPK:BLKCF</a>, <a href='https://seekingalpha.com/symbol/CRCW' title='The Crypto Company'>OTC:CRCW</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3317173\" data-linked=\"Bitcoin lower by 11% ahead of futures opening\" data-tweet=\"$CBOE $CBOE $GBTC - Bitcoin lower by 11% ahead of futures opening https://seekingalpha.com/news/3317173-bitcoin-lower-11-ahead-of-futures-opening?source=tweet\" data-url=\"https://seekingalpha.com/news/3317173-bitcoin-lower-11-ahead-of-futures-opening\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>54&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":45,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}